Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.

Pontecorvo MJ, Devous MD, Kennedy I, Navitsky M, Lu M, Galante N, Salloway S, Doraiswamy PM, Southekal S, Arora AK, McGeehan A, Lim NC, Xiong H, Truocchio SP, Joshi AD, Shcherbinin S, Teske B, Fleisher AS, Mintun MA.

Brain. 2019 Jun 1;142(6):1723-1735. doi: 10.1093/brain/awz090.

2.

Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.

Petrella JR, Hao W, Rao A, Doraiswamy PM.

Comput Math Methods Med. 2019 Feb 3;2019:6216530. doi: 10.1155/2019/6216530. eCollection 2019.

3.

Lifestyle and neurocognition in older adults with cognitive impairments: A randomized trial.

Blumenthal JA, Smith PJ, Mabe S, Hinderliter A, Lin PH, Liao L, Welsh-Bohmer KA, Browndyke JN, Kraus WE, Doraiswamy PM, Burke JR, Sherwood A.

Neurology. 2019 Jan 15;92(3):e212-e223. doi: 10.1212/WNL.0000000000006784. Epub 2018 Dec 19.

PMID:
30568005
4.

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.

Nho K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Jia W, Xie G, Ahmad S, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, Saykin AJ, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2019 Feb;15(2):232-244. doi: 10.1016/j.jalz.2018.08.012. Epub 2018 Oct 15.

5.

Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.

MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, St John Williams L, Tenenbaum JD, Blach C, Baillie R, Han X, Bhattacharyya S, Toledo JB, Schafferer S, Klein S, Koal T, Risacher SL, Kling MA, Motsinger-Reif A, Rotroff DM, Jack J, Hankemeier T, Bennett DA, De Jager PL, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn CM, Saykin AJ, Kastenmüller G, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2019 Jan;15(1):76-92. doi: 10.1016/j.jalz.2018.07.217. Epub 2018 Oct 15. Erratum in: Alzheimers Dement. 2019 Apr;15(4):604.

6.

Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.

Ong SS, Proia AD, Whitson HE, Farsiu S, Doraiswamy PM, Lad EM.

J Neurol. 2019 Jul;266(7):1566-1577. doi: 10.1007/s00415-018-9028-z. Epub 2018 Aug 28. Review.

PMID:
30155741
7.

Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.

Devanand DP, Pelton GH, D'Antonio K, Ciarleglio A, Scodes J, Andrews H, Lunsford J, Beyer JL, Petrella JR, Sneed J, Ciovacco M, Doraiswamy PM.

Am J Geriatr Psychiatry. 2018 Oct;26(10):1050-1060. doi: 10.1016/j.jagp.2018.05.008. Epub 2018 Jun 28.

8.

Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.

Motter JN, Pelton GH, D'Antonio K, Rushia SN, Pimontel MA, Petrella JR, Garcon E, Ciovacco MW, Sneed JR, Doraiswamy PM, Devanand DP.

Int J Geriatr Psychiatry. 2018 Dec;33(12):1604-1612. doi: 10.1002/gps.4955. Epub 2018 Jul 23.

PMID:
30035339
9.

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease.

Sohn D, Shpanskaya K, Lucas JE, Petrella JR, Saykin AJ, Tanzi RE, Samatova NF, Doraiswamy PM.

Sci Rep. 2018 May 10;8(1):7490. doi: 10.1038/s41598-018-25377-w.

10.

Controversies and Future Directions of Ocular Biomarkers in Alzheimer Disease.

Ong SS, Doraiswamy PM, Lad EM.

JAMA Neurol. 2018 Jun 1;75(6):650-651. doi: 10.1001/jamaneurol.2018.0602. No abstract available.

PMID:
29710250
11.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP; Alzheimer’s Disease Neuroimaging Initiative (ADNI) Study Group; Neurologic Outcomes Research Group (NORG).

Anesthesiology. 2018 Apr;128(4):728-744. doi: 10.1097/ALN.0000000000002103.

12.

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.

Varma VR, Oommen AM, Varma S, Casanova R, An Y, Andrews RM, O'Brien R, Pletnikova O, Troncoso JC, Toledo J, Baillie R, Arnold M, Kastenmueller G, Nho K, Doraiswamy PM, Saykin AJ, Kaddurah-Daouk R, Legido-Quigley C, Thambisetty M.

PLoS Med. 2018 Jan 25;15(1):e1002482. doi: 10.1371/journal.pmed.1002482. eCollection 2018 Jan.

13.

Change in Sense of Nondual Awareness and Spiritual Awakening in Response to a Multidimensional Well-Being Program.

Mills PJ, Peterson CT, Pung MA, Patel S, Weiss L, Wilson KL, Doraiswamy PM, Martin JA, Tanzi RE, Chopra D.

J Altern Complement Med. 2018 Apr;24(4):343-351. doi: 10.1089/acm.2017.0160. Epub 2017 Dec 7.

PMID:
29216441
14.

Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps.

Padmanabhan K, Shpanskaya K, Bello G, Doraiswamy PM, Samatova NF.

Front Aging Neurosci. 2017 Sep 26;9:315. doi: 10.3389/fnagi.2017.00315. eCollection 2017. No abstract available.

15.

Effectiveness of Florbetapir PET Imaging in Changing Patient Management.

Pontecorvo MJ, Siderowf A, Dubois B, Doraiswamy PM, Frisoni GB, Grundman M, Nobili F, Sadowsky CH, Salloway S, Arora AK, Chevrette A, Deberdt W, Dell'Agnello G, Flitter M, Galante N, Lowrey MJ, Lu M, McGeehan A, Devous MD Sr, Mintun MA.

Dement Geriatr Cogn Disord. 2017;44(3-4):129-143. doi: 10.1159/000478007. Epub 2017 Aug 5.

16.

Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease.

Gamberger D, Lavrač N, Srivatsa S, Tanzi RE, Doraiswamy PM.

Sci Rep. 2017 Jul 28;7(1):6763. doi: 10.1038/s41598-017-06624-y.

17.

Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients.

Lee E, Giovanello KS, Saykin AJ, Xie F, Kong D, Wang Y, Yang L, Ibrahim JG, Doraiswamy PM, Zhu H.

Alzheimers Dement (Amst). 2017 Apr 23;8:86-95. doi: 10.1016/j.dadm.2017.04.004. eCollection 2017.

18.

Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment.

Blumenthal JA, Smith PJ, Mabe S, Hinderliter A, Welsh-Bohmer K, Browndyke JN, Lin PH, Kraus W, Doraiswamy PM, Burke J, Sherwood A.

Psychosom Med. 2017 Jul/Aug;79(6):719-727. doi: 10.1097/PSY.0000000000000474.

19.

Metabolic network failures in Alzheimer's disease: A biochemical road map.

Toledo JB, Arnold M, Kastenmüller G, Chang R, Baillie RA, Han X, Thambisetty M, Tenenbaum JD, Suhre K, Thompson JW, John-Williams LS, MahmoudianDehkordi S, Rotroff DM, Jack JR, Motsinger-Reif A, Risacher SL, Blach C, Lucas JE, Massaro T, Louie G, Zhu H, Dallmann G, Klavins K, Koal T, Kim S, Nho K, Shen L, Casanova R, Varma S, Legido-Quigley C, Moseley MA, Zhu K, Henrion MYR, van der Lee SJ, Harms AC, Demirkan A, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Saykin AJ, Weiner MW, Doraiswamy PM, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

Alzheimers Dement. 2017 Sep;13(9):965-984. doi: 10.1016/j.jalz.2017.01.020. Epub 2017 Mar 22.

20.

No calorie comfort: Viewing and drawing "comfort foods" similarly augment positive mood for those with depression.

Privitera GJ, Welling D, Tejada G, Sweazy N, Cuifolo KN, King-Shepard QW, Doraiswamy PM.

J Health Psychol. 2018 Mar;23(4):598-607. doi: 10.1177/1359105316681861. Epub 2016 Dec 12.

PMID:
27956477
21.

Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition?

Motter JN, Devanand DP, Doraiswamy PM, Sneed JR.

Front Aging Neurosci. 2016 Nov 2;8:249. eCollection 2016. No abstract available.

22.

A New Spin on Neural Processing: Quantum Cognition.

Weingarten CP, Doraiswamy PM, Fisher MP.

Front Hum Neurosci. 2016 Oct 26;10:541. eCollection 2016. No abstract available.

23.

Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment.

Lin KA, Rundel C, Doraiswamy PM; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;55(3):1123-1130.

PMID:
27767986
24.

Corrigendum: Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI).

Peterson CT, Lucas J, John-Williams LS, Thompson JW, Moseley MA, Patel S, Peterson SN, Porter V, Schadt EE, Mills PJ, Tanzi RE, Doraiswamy PM, Chopra D.

Sci Rep. 2016 Oct 10;6:34678. doi: 10.1038/srep34678. No abstract available.

25.

Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI).

Peterson CT, Lucas J, John-Williams LS, Thompson JW, Moseley MA, Patel S, Peterson SN, Porter V, Schadt EE, Mills PJ, Tanzi RE, Doraiswamy PM, Chopra D.

Sci Rep. 2016 Sep 9;6:32609. doi: 10.1038/srep32609. Erratum in: Sci Rep. 2016 Oct 10;6:34678.

26.

Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action.

Shin J, Doraiswamy PM.

Front Aging Neurosci. 2016 Jun 3;8:123. doi: 10.3389/fnagi.2016.00123. eCollection 2016. No abstract available.

27.

The Self-Directed Biological Transformation Initiative and Well-Being.

Mills PJ, Wilson KL, Pung MA, Weiss L, Patel S, Doraiswamy PM, Peterson CT, Porter V, Schadt E, Chopra D, Tanzi RE.

J Altern Complement Med. 2016 Aug;22(8):627-34. doi: 10.1089/acm.2016.0002. Epub 2016 Jun 28.

PMID:
27351443
28.

A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings.

Cecchi M, Moore DK, Sadowsky CH, Solomon PR, Doraiswamy PM, Smith CD, Jicha GA, Budson AE, Arnold SE, Fadem KC.

Alzheimers Dement (Amst). 2015 Oct 2;1(4):387-94. doi: 10.1016/j.dadm.2015.08.004. eCollection 2015 Dec.

29.

Differential food intake and food choice by depression and body mass index levels following a mood manipulation in a buffet-style setting.

Privitera GJ, King-Shepard QW, Cuifolo KN, Doraiswamy PM.

J Health Psychol. 2019 Feb;24(2):199-208. doi: 10.1177/1359105316650508. Epub 2016 May 20.

PMID:
27206838
30.

The Alzheimer Structural Connectome: Changes in Cortical Network Topology with Increased Amyloid Plaque Burden.

Prescott JW, Guidon A, Doraiswamy PM, Choudhury KR, Liu C, Petrella JR; Alzheimer’s Disease Neuroimaging Initiative.

Radiology. 2016 Apr;279(1):328. doi: 10.1148/radiol.2016164007. No abstract available.

31.

Accelerating stem cell trials for Alzheimer's disease.

Hunsberger JG, Rao M, Kurtzberg J, Bulte JWM, Atala A, LaFerla FM, Greely HT, Sawa A, Gandy S, Schneider LS, Doraiswamy PM.

Lancet Neurol. 2016 Feb;15(2):219-230. doi: 10.1016/S1474-4422(15)00332-4. Epub 2015 Dec 17. Review. Erratum in: Lancet Neurol. 2016 Feb;15(2):135.

PMID:
26704439
32.

Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.

Kim S, Nho K, Ramanan VK, Lai D, Foroud TM, Lane K, Murrell JR, Gao S, Hall KS, Unverzagt FW, Baiyewu O, Ogunniyi A, Gureje O, Kling MA, Doraiswamy PM, Kaddurah-Daouk R, Hendrie HC, Saykin AJ.

J Alzheimers Dis. 2016;49(4):991-1003. doi: 10.3233/JAD-150651.

33.

Computerized Cognitive Training for Major Depressive Disorder: What's Next?

Motter JN, Devanand DP, Doraiswamy PM, Sneed JR.

Front Psychiatry. 2015 Oct 1;6:137. doi: 10.3389/fpsyt.2015.00137. eCollection 2015. Review. No abstract available.

34.

Marked gender differences in progression of mild cognitive impairment over 8 years.

Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement (N Y). 2015 Sep 1;1(2):103-110.

35.

Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE.

Sundman M, Doraiswamy PM, Morey RA.

Front Neurosci. 2015 Sep 24;9:334. doi: 10.3389/fnins.2015.00334. eCollection 2015. Review.

36.

Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis.

Motter JN, Pimontel MA, Rindskopf D, Devanand DP, Doraiswamy PM, Sneed JR.

J Affect Disord. 2016 Jan 1;189:184-91. doi: 10.1016/j.jad.2015.09.022. Epub 2015 Sep 26. Review.

PMID:
26437233
37.

Eat now or later: self-control as an overlapping cognitive mechanism of depression and obesity.

Privitera GJ, McGrath HK, Windus BA, Doraiswamy PM.

PLoS One. 2015 Mar 26;10(3):e0123136. doi: 10.1371/journal.pone.0123136. eCollection 2015.

38.

PET Imaging of Tau Pathology in Alzheimer's Disease and Tauopathies.

James OG, Doraiswamy PM, Borges-Neto S.

Front Neurol. 2015 Mar 9;6:38. doi: 10.3389/fneur.2015.00038. eCollection 2015. Review. No abstract available.

39.

When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer's Disease.

Lin KA, Doraiswamy PM.

Front Neurol. 2015 Jan 12;5:288. doi: 10.3389/fneur.2014.00288. eCollection 2014. Review. No abstract available.

40.

Exercise to combat depression.

Blumenthal JA, Doraiswamy PM.

JAMA. 2014 Nov 26;312(20):2166-7. doi: 10.1001/jama.2014.14334. No abstract available.

PMID:
25423225
41.

Brain atrophy rates in first degree relatives at risk for Alzheimer's.

Lampert EJ, Roy Choudhury K, Hostage CA, Rathakrishnan B, Weiner M, Petrella JR, Doraiswamy PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Sep 4;6:340-6. doi: 10.1016/j.nicl.2014.08.024. eCollection 2014.

42.

Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review.

Keefe RS, McClintock SM, Roth RM, Doraiswamy PM, Tiger S, Madhoo M.

J Clin Psychiatry. 2014 Aug;75(8):864-76. doi: 10.4088/JCP.13r08609. Review.

43.

Preimplantation genetic diagnosis for inherited neurological disorders.

Tur-Kaspa I, Jeelani R, Doraiswamy PM.

Nat Rev Neurol. 2014 Jul;10(7):417-24. doi: 10.1038/nrneurol.2014.84. Epub 2014 May 27. Review.

PMID:
24866878
44.

The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.

Prescott JW, Guidon A, Doraiswamy PM, Roy Choudhury K, Liu C, Petrella JR; Alzheimer’s Disease Neuroimaging Initiative.

Radiology. 2014 Oct;273(1):175-84. doi: 10.1148/radiol.14132593. Epub 2014 May 22. Erratum in: Radiology. 2016 Apr;279(1):328.

45.

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group; AV45-A11 Study Group.

Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.

46.

Preimplantation genetic diagnosis (PGD) for genetic prion disorder due to F198S mutation in the PRNP gene.

Uflacker A, Doraiswamy PM, Rechitsky S, See T, Geschwind M, Tur-Kaspa I.

JAMA Neurol. 2014 Apr;71(4):484-6. doi: 10.1001/jamaneurol.2013.5884. Review.

47.

Educational attainment and hippocampal atrophy in the Alzheimer's disease neuroimaging initiative cohort.

Shpanskaya KS, Choudhury KR, Hostage C Jr, Murphy KR, Petrella JR, Doraiswamy PM; Alzheimer's Disease Neuroimaging Initiative.

J Neuroradiol. 2014 Dec;41(5):350-7. doi: 10.1016/j.neurad.2013.11.004. Epub 2014 Jan 30.

PMID:
24485897
48.

Science to practice: translating automated brain MRI volumetry in Alzheimer's disease from research to routine diagnostic use in the work-up of dementia.

Rathakrishnan BG, Doraiswamy PM, Petrella JR.

Front Neurol. 2014 Jan 9;4:216. doi: 10.3389/fneur.2013.00216. Review. No abstract available.

49.

Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.

Dugger BN, Clark CM, Serrano G, Mariner M, Bedell BJ, Coleman RE, Doraiswamy PM, Lu M, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Zehntner SP, Carpenter AP, Joshi AD, Mintun MA, Pontecorvo MJ, Skovronsky DM, Sue LI, Beach TG.

J Neuropathol Exp Neurol. 2014 Jan;73(1):72-80. doi: 10.1097/NEN.0000000000000028.

50.

Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.

Pelton GH, Andrews H, Roose SP, Marcus SM, D'Antonio K, Husn H, Petrella JR, Zannas AS, Doraiswamy PM, Devanand DP.

Contemp Clin Trials. 2014 Mar;37(2):200-8. doi: 10.1016/j.cct.2013.11.015. Epub 2013 Dec 5.

Supplemental Content

Loading ...
Support Center